510(k) K991660

COPALIS MULTIPLEX EBV ANTIBODY ASSAY by DiaSorin, Inc. — Product Code LSE

K991660 is an FDA 510(k) premarket notification submitted by DiaSorin, Inc. for the device "COPALIS MULTIPLEX EBV ANTIBODY ASSAY". The FDA issued a decision of Substantially Equivalent on June 4, 1999. The device falls under product code LSE (Epstein-Barr Virus, Other), a Class I device regulated under 21 CFR 866.3235. DiaSorin, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
June 4, 1999
Date Received
May 14, 1999
Clearance Type
Traditional
Expedited Review
No
Third Party Review
Yes

Device Classification

Device Name
Epstein-Barr Virus, Other
Device Class
Class I
Regulation Number
866.3235
Review Panel
MI
Submission Type